Levofloxacin Macure

Levofloxacin, the active ingredient in Levofloxacin Macure, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, exacerbations of chronic bronchitis, uncomplicated urinary tract infections, and skin and soft‑tissue infections in adult patients.

GNH USA supplies Levofloxacin Macure as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Levofloxacin is indicated for several bacterial infections affecting the respiratory, urinary and skin systems.

- Community‑acquired pneumonia: eradicates the typical pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbation of chronic bronchitis: shortens the duration of worsening symptoms. - Uncomplicated urinary tract infection: eliminates uropathogens and resolves urinary symptoms. - Skin and soft‑tissue infections: treats cellulitis and other bacterial skin conditions.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Insomnia: difficulty falling or staying asleep. - Abdominal pain: cramping or discomfort.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or loss of function. - QT interval prolongation: risk of cardiac arrhythmia. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Peripheral neuropathy: tingling or numbness in extremities. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing Levofloxacin, clinicians should consider several safety factors.

- Renal impairment: dose adjustment may be required in reduced kidney function. - Central nervous system effects: monitor for seizures or confusion, especially in the elderly. - QT prolongation risk: avoid in patients with known cardiac conduction disorders. - Photosensitivity: advise patients to limit sun exposure and use protective clothing. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Levofloxacin can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids, iron, or sucralfate: reduce levofloxacin absorption; separate dosing by at least 2 hours. - Warfarin: may increase anticoagulant effect and bleeding risk. - Theophylline or cyclosporine: plasma levels can rise, leading to toxicity. - Other QT‑prolonging agents: additive risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of tendon rupture. - Diabetic agents: possible hypoglycemia; monitor blood glucose. - Antihistamines: may increase central nervous system stimulation.